IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
Not yet recruiting · NCT06434025 · Registry updated 2024-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | Iron Deficiencies, Nutritional and Metabolic Diseases, cardiovascular disorder, heart disorder, heart failure, iron metabolism disease, metabolic disease, systolic heart failure | Not yet recruiting | Phase 3 | 2024-06-03 | NCT06434025 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospital de Clinicas de Porto Alegre | 54 |
| Vifor Pharma | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital de Clínicas de Porto Alegre | Porto Alegre | Brazil | 1 |